Invention Grant
US09278098B2 Substituted phthalazines for inducing insulin secretion and protecting beta-cells
有权
用于诱导胰岛素分泌和保护β-细胞的取代的酞嗪
- Patent Title: Substituted phthalazines for inducing insulin secretion and protecting beta-cells
- Patent Title (中): 用于诱导胰岛素分泌和保护β-细胞的取代的酞嗪
-
Application No.: US14524724Application Date: 2014-10-27
-
Publication No.: US09278098B2Publication Date: 2016-03-08
- Inventor: Timothy L. MacDonald , Jerry L. Nadler , Peng Cui
- Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
- Applicant Address: US VA Charlottesville
- Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
- Current Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
- Current Assignee Address: US VA Charlottesville
- Agent Rodney L. Sparks
- Main IPC: C07D237/32
- IPC: C07D237/32 ; A61K31/502

Abstract:
Phthalazine analogs of a Lisofylline (LSF) and synthetic methods for preparation of such analogs are provided. Compounds of the invention have structural formula III: wherein 1) R3a is hydrogen and R3b is selected from C5-22alkyl, C2-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof; or 2) R3b is hydrogen and R3a is selected from C9alkyl, C15-22alkyl, C9-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof; or 3) R3a and R3b are the same or different and are selected from C9alkyl, C15-22alkyl, C4-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof. The analogs of LSF provided have the ability to protect cell viability, particularly the ability to protect pancreatic β-cells, to induce insulin secretion.
Public/Granted literature
- US20150164892A1 LISOFYLLINE ANALOGS AND METHODS FOR USE Public/Granted day:2015-06-18
Information query